Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV002283506 | SCV002572807 | uncertain significance | Focal segmental glomerulosclerosis 2 | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with TRPC6-related disorder (ClinVar ID: VCV000562400). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |
Gharavi Laboratory, |
RCV000681865 | SCV000809344 | likely pathogenic | not provided | 2018-09-16 | no assertion criteria provided | research |